WASHINGTON — Treating mild chronic hypertension during pregnancy to a BP goal of less than 140/90 mm Hg reduced adverse pregnancy outcomes and did not impair fetal growth, according to a new study.
Pregnant women with mild chronic hypertension who received antihypertensive medication had significantly reduced rates of severe preeclampsia, preterm birth before 35 weeks’ gestation, placental abruption and fetal or neonatal death compared with a strategy of reserving treatment only for women who developed severe hypertension during pregnancy.
Further, there was no increase in risk for